Growth Metrics

Ardelyx (ARDX) Free Cash Flow Growth (1y) (2014 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Growth (1y) (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn - 60.84%
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn - -
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn 88.70%
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn - -
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn - -15.72%
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn 66.37%
7 Evaxion A 64.16 Bn 64.14 Bn - -
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn 3.98%
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn 137.65%
10 Ardelyx 1.48 Bn 1.25 Bn 89.66 Mn 16.70%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 16.70%
Dec 31, 2025 123.39%
Sep 30, 2025 -42.58%
Jun 30, 2025 -33.09%
Mar 31, 2025 -8.11%
Dec 31, 2024 205.20%
Sep 30, 2024 101.68%
Jun 30, 2024 -31.69%
Mar 31, 2024 19.94%
Dec 31, 2023 -161.57%
Sep 30, 2023 14.81%
Jun 30, 2023 52.59%
Mar 31, 2023 -62.23%
Dec 31, 2022 136.14%
Sep 30, 2022 27.42%
Jun 30, 2022 10.66%
Mar 31, 2022 38.62%
Dec 31, 2021 -120.71%
Sep 30, 2021 -75.82%
Jun 30, 2021 -84.08%
Mar 31, 2021 -80.19%
Dec 31, 2020 -60.19%
Sep 30, 2020 3.87%
Jun 30, 2020 31.74%
Mar 31, 2020 -46.22%
Dec 31, 2019 40.52%
Sep 30, 2019 23.20%
Jun 30, 2019 -54.68%
Mar 31, 2019 -148.99%
Dec 31, 2018 -500.92%
Sep 30, 2018 -37.27%
Jun 30, 2018 26.99%
Mar 31, 2018 75.40%
Dec 31, 2017 115.83%
Sep 30, 2017 25.10%
Jun 30, 2017 2.07%
Mar 31, 2017 -69.51%
Dec 31, 2016 -33.77%
Sep 30, 2016 -78.94%
Jun 30, 2016 16.36%
Mar 31, 2016 -94.80%
Dec 31, 2015 -357.23%
Sep 30, 2015 -154.11%
Jun 30, 2015 -229.00%
Mar 31, 2015 -595.47%
Dec 31, 2014 -143.13%
Sep 30, 2014 -2,524.09%